• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BIOL

BIOL

BIOLASE, Inc.

NASDAQHealthcareMedical - DevicesUS

USD0.02

+0.00 (+27.39%)

Company Profile

CEO

John R. Beaver

IPO Date

1992-11-12

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.05

Prev. Close

$0.02

Day Low

$0.02

Day High

$0.05

52W Low

$0.02

52W High

$1.94

Market Cap

$0.00B

Volume

2.67M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.3%

Avg Negative

3.2%

Avg Neutral

62.5%

News Feed

BIOLASE Announces Clinical Advisory Partnership with Leading Endodontist Dr. L. Stephen Buchanan

PRNewsWire·8/31/2021·↑ positive

Can BIOLASE (BIOL) Stock Continue to Grow Earnings?

Zacks Investment Research·8/19/2021·↑ positive

BIOLASE Expands Core Capabilities As It Appoints Three New Board Members With Significant Dental Experience

PRNewsWire·8/16/2021·↑ positive

3 Biotech Penny Stocks To Watch Making Big Waves in 2021

PennyStocks·8/13/2021·↑ positive

Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings

Benzinga·8/13/2021·↑ positive

BIOLASE Shares Increase Over 30% Pre-Market: Why It Happened

Pulse2·8/13/2021·↑ positive

BIOLASE, Inc. (BIOL) CEO John Beaver on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/12/2021·↓ negative

Biolase: Q2 Earnings Insights

Benzinga·8/12/2021·↑ positive

BIOLASE, Inc. To Report Second Quarter 2021 Results On August 12, 2021

PRNewsWire·8/5/2021·↓ negative

Best Growth Penny Stocks for 2021, Are Small-Caps Worth Watching?

PennyStocks·6/11/2021·↑ positive